Cargando…
Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the fourth leading cause of cancer-related mortality worldwide. Thus, identification of the mechanisms involved in the progression of CRC has become a crucial element of facilitating early CRC diagnosis and targeted therapy for...
Autores principales: | Hou, Bin, Li, Wenhan, Li, Jianhui, Ma, Jia, Xia, Peng, Liu, Zhao, Zeng, Qingnuo, Zhang, Xin, Chang, Dongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967159/ https://www.ncbi.nlm.nih.gov/pubmed/31894339 http://dx.doi.org/10.3892/or.2019.7442 |
Ejemplares similares
-
LHPP suppresses colorectal cancer cell migration and invasion in vitro and in vivo by inhibiting Smad3 phosphorylation in the TGF-β pathway
por: Hou, Bin, et al.
Publicado: (2021) -
LHPP suppresses gastric cancer progression via the PI3K/AKT/mTOR signaling pathway
por: Wang, Danfang, et al.
Publicado: (2022) -
As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma
por: Liu, Shanshan, et al.
Publicado: (2022) -
Efficiency of CAR-T Therapy for Treatment of Solid Tumor in Clinical Trials: A Meta-Analysis
por: Hou, Bin, et al.
Publicado: (2019) -
LHPP Inhibits the Proliferation and Metastasis of Renal Cell Carcinoma
por: Zhang, Xiaoting, et al.
Publicado: (2020)